Microbot Medical (MBOT) Competitors $1.84 -0.01 (-0.54%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$1.84 0.00 (0.00%) As of 01/31/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends MBOT vs. SGHT, PDEX, ZJYL, LNSR, SRTS, ECOR, MLSS, TELA, FONR, and GUTSShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Sight Sciences (SGHT), Pro-Dex (PDEX), Jin Medical International (ZJYL), LENSAR (LNSR), Sensus Healthcare (SRTS), electroCore (ECOR), Milestone Scientific (MLSS), TELA Bio (TELA), FONAR (FONR), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Sight Sciences Pro-Dex Jin Medical International LENSAR Sensus Healthcare electroCore Milestone Scientific TELA Bio FONAR Fractyl Health Microbot Medical (NASDAQ:MBOT) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, community ranking, profitability, valuation and dividends. Does the MarketBeat Community prefer MBOT or SGHT? Microbot Medical received 330 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 70.73% of users gave Microbot Medical an outperform vote while only 30.00% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformMicrobot MedicalOutperform Votes34870.73% Underperform Votes14429.27% Sight SciencesOutperform Votes1830.00% Underperform Votes4270.00% Do analysts recommend MBOT or SGHT? Microbot Medical presently has a consensus target price of $9.00, suggesting a potential upside of 389.13%. Sight Sciences has a consensus target price of $4.62, suggesting a potential upside of 65.00%. Given Microbot Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Microbot Medical is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Which has more risk and volatility, MBOT or SGHT? Microbot Medical has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.57, meaning that its share price is 157% more volatile than the S&P 500. Is MBOT or SGHT more profitable? Microbot Medical has a net margin of 0.00% compared to Sight Sciences' net margin of -63.30%. Sight Sciences' return on equity of -47.28% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -218.30% -158.17% Sight Sciences -63.30%-47.28%-32.72% Do insiders & institutionals believe in MBOT or SGHT? 16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 55.5% of Sight Sciences shares are owned by institutional investors. 10.5% of Microbot Medical shares are owned by insiders. Comparatively, 28.9% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer MBOT or SGHT? In the previous week, Sight Sciences had 3 more articles in the media than Microbot Medical. MarketBeat recorded 7 mentions for Sight Sciences and 4 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.63 beat Sight Sciences' score of 0.29 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sight Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, MBOT or SGHT? Microbot Medical has higher earnings, but lower revenue than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$10.74M-$0.80-2.30Sight Sciences$81.06M1.75-$55.55M-$1.02-2.75 SummaryMicrobot Medical beats Sight Sciences on 8 of the 15 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.24M$4.80B$5.57B$9.12BDividend YieldN/A51.39%5.31%3.99%P/E Ratio-2.3025.9787.7617.96Price / SalesN/A57.661,224.7575.80Price / CashN/A52.1145.9637.70Price / Book4.848.145.124.71Net Income-$10.74M$89.07M$111.17M$224.24M7 Day Performance-9.36%-2.28%2.38%-0.17%1 Month Performance64.29%8.36%3.20%0.60%1 Year Performance42.64%29.54%24.70%20.43% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical2.4737 of 5 stars$1.84-0.5%$9.00+389.1%+42.6%$37.25MN/A-2.3020Gap UpSGHTSight Sciences3.7782 of 5 stars$2.92-0.3%$4.62+58.2%-34.0%$147.95M$79.54M-2.86210PDEXPro-Dex4.2135 of 5 stars$41.52+2.1%$52.00+25.2%+76.4%$135.52M$53.84M26.99140Earnings ReportInsider TradeNews CoverageZJYLJin Medical InternationalN/A$0.81-9.3%N/A-99.7%$125.09M$19.82M0.00245Short Interest ↓News CoverageLNSRLENSAR1.3217 of 5 stars$10.80+14.6%$8.00-25.9%+212.7%$124.92M$42.16M-7.37110High Trading VolumeSRTSSensus Healthcare3.4594 of 5 stars$6.81-4.7%$12.50+83.7%+153.2%$111.58M$24.41M11.9440Upcoming EarningsAnalyst ForecastShort Interest ↑News CoverageGap UpECORelectroCore2.974 of 5 stars$16.47-3.2%$25.00+51.8%+120.9%$107.85M$16.03M-9.0050Short Interest ↓News CoverageMLSSMilestone Scientific0.5513 of 5 stars$1.35+1.5%$1.25-7.4%+120.8%$105.15M$9.83M-19.2830Analyst ForecastTELATELA Bio2.5498 of 5 stars$2.65-0.7%$9.25+249.1%-61.8%$104.38M$58.45M-1.57120FONRFONAR1.2456 of 5 stars$15.78-1.4%N/A-19.5%$99.86M$102.88M11.27480Short Interest ↑News CoverageGUTSFractyl Health1.7804 of 5 stars$2.07-1.2%$22.00+965.4%N/A$98.85M$120,000.00-0.17102Short Interest ↑News CoveragePositive News Related Companies and Tools Related Companies Sight Sciences Alternatives Pro-Dex Alternatives Jin Medical International Alternatives LENSAR Alternatives Sensus Healthcare Alternatives electroCore Alternatives Milestone Scientific Alternatives TELA Bio Alternatives FONAR Alternatives Fractyl Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MBOT) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
